UNCY
Unicycive Therapeutics (UNCY)
$88
About Unicycive Therapeutics (UNCY)
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
Details
Daily high
$6.05
Daily low
$5.85
Price at open
$5.89
52 Week High
$11.00
52 Week Low
$3.71
Market cap
126.4M
Dividend yield
0.00%
Volume
212,730
Avg. volume
346,413
P/E ratio
-1.81
Unicycive Therapeutics News
Details
Daily high
$6.05
Daily low
$5.85
Price at open
$5.89
52 Week High
$11.00
52 Week Low
$3.71
Market cap
126.4M
Dividend yield
0.00%
Volume
212,730
Avg. volume
346,413
P/E ratio
-1.81